KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $554,360 | -13.1% | 57,566 | -18.8% | 0.00% | – |
Q2 2023 | $637,785 | -42.8% | 70,865 | -50.0% | 0.00% | – |
Q1 2023 | $1,114,468 | -87.4% | 141,790 | -89.2% | 0.00% | -100.0% |
Q4 2022 | $8,862,374 | -47.3% | 1,311,002 | +13.2% | 0.00% | -50.0% |
Q3 2022 | $16,808,000 | +50.8% | 1,158,385 | +2.3% | 0.00% | +100.0% |
Q2 2022 | $11,143,000 | -8.4% | 1,132,442 | +37.2% | 0.00% | 0.0% |
Q1 2022 | $12,166,000 | +16.8% | 825,350 | +4.8% | 0.00% | 0.0% |
Q4 2021 | $10,415,000 | -37.9% | 787,220 | -18.1% | 0.00% | 0.0% |
Q3 2021 | $16,769,000 | -35.7% | 960,961 | -11.7% | 0.00% | -50.0% |
Q2 2021 | $26,087,000 | -24.7% | 1,088,790 | -19.2% | 0.00% | -33.3% |
Q1 2021 | $34,630,000 | +11.2% | 1,347,970 | -17.8% | 0.00% | 0.0% |
Q4 2020 | $31,149,000 | +42.1% | 1,640,278 | -5.8% | 0.00% | +50.0% |
Q3 2020 | $21,926,000 | +2.7% | 1,741,613 | -1.3% | 0.00% | 0.0% |
Q2 2020 | $21,342,000 | +55.8% | 1,763,856 | -1.5% | 0.00% | 0.0% |
Q1 2020 | $13,700,000 | -53.9% | 1,790,791 | +7.4% | 0.00% | -33.3% |
Q4 2019 | $29,689,000 | +176.7% | 1,666,978 | +80.2% | 0.00% | +200.0% |
Q3 2019 | $10,729,000 | -50.4% | 924,945 | -5.3% | 0.00% | -66.7% |
Q2 2019 | $21,629,000 | +2.8% | 976,480 | +32.9% | 0.00% | 0.0% |
Q1 2019 | $21,036,000 | – | 735,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |